Literature DB >> 22971058

Novel selective allosteric and bitopic ligands for the S1P(3) receptor.

Euijung Jo1, Barun Bhhatarai, Emanuela Repetto, Miguel Guerrero, Sean Riley, Steven J Brown, Yasushi Kohno, Edward Roberts, Stephan C Schürer, Hugh Rosen.   

Abstract

Sphingosine 1-phosphate (S1P) is a lysophospholipid signaling molecule that regulates important biological functions, including lymphocyte trafficking and vascular development, by activating G protein-coupled receptors for S1P, namely, S1P(1) through S1P(5). Here, we map the S1P(3) binding pocket with a novel allosteric agonist (CYM-5541), an orthosteric agonist (S1P), and a novel bitopic antagonist (SPM-242). With a combination of site-directed mutagenesis, ligand competition assay, and molecular modeling, we concluded that S1P and CYM-5541 occupy different chemical spaces in the ligand binding pocket of S1P(3). CYM-5541 allowed us to identify an allosteric site where Phe263 is a key gate-keeper residue for its affinity and efficacy. This ligand lacks a polar moiety, and the novel allosteric hydrophobic pocket permits S1P(3) selectivity of CYM-5541 within the highly similar S1P receptor family. However, a novel S1P(3)-selective antagonist, SPM-242, in the S1P(3) pocket occupies the ligand binding spaces of both S1P and CYM-5541, showing its bitopic mode of binding. Therefore, our coordinated approach with biochemical data and molecular modeling, based on our recently published S1P(1) crystal structure data in a highly conserved set of related receptors with a shared ligand, provides a strong basis for the successful optimization of orthosteric, allosteric, and bitopic modulators of S1P(3).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22971058      PMCID: PMC3528827          DOI: 10.1021/cb300392z

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  36 in total

1.  S1P activates store-operated calcium entry via receptor- and non-receptor-mediated pathways in vascular smooth muscle cells.

Authors:  Kristen Park Hopson; Jessica Truelove; Jerold Chun; Yumei Wang; Christian Waeber
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-26       Impact factor: 4.249

Review 2.  Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.

Authors:  Jason G Cyster; Susan R Schwab
Journal:  Annu Rev Immunol       Date:  2011-12-05       Impact factor: 28.527

3.  S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate.

Authors:  Euijung Jo; M Germana Sanna; Pedro J Gonzalez-Cabrera; Shobha Thangada; Gabor Tigyi; Daniel A Osborne; Timothy Hla; Abby L Parrill; Hugh Rosen
Journal:  Chem Biol       Date:  2005-06

Review 4.  Modulating tone: the overture of S1P receptor immunotherapeutics.

Authors:  Hugh Rosen; Pedro Gonzalez-Cabrera; David Marsolais; Stuart Cahalan; Anthony S Don; M Germana Sanna
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

Review 5.  Tipping the gatekeeper: S1P regulation of endothelial barrier function.

Authors:  Hugh Rosen; M Germana Sanna; Stuart M Cahalan; Pedro J Gonzalez-Cabrera
Journal:  Trends Immunol       Date:  2007-02-05       Impact factor: 16.687

Review 6.  The best of both worlds? Bitopic orthosteric/allosteric ligands of g protein-coupled receptors.

Authors:  Celine Valant; J Robert Lane; Patrick M Sexton; Arthur Christopoulos
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-09-09       Impact factor: 13.820

7.  Sphingosine 1-phosphate stimulation of the p42/p44 mitogen-activated protein kinase pathway in airway smooth muscle. Role of endothelial differentiation gene 1, c-Src tyrosine kinase and phosphoinositide 3-kinase.

Authors:  S Rakhit; A M Conway; R Tate; T Bower; N J Pyne; S Pyne
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

8.  Finding a way out: lymphocyte egress from lymphoid organs.

Authors:  Susan R Schwab; Jason G Cyster
Journal:  Nat Immunol       Date:  2007-12       Impact factor: 25.606

Review 9.  Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.

Authors:  P Jeffrey Conn; Arthur Christopoulos; Craig W Lindsley
Journal:  Nat Rev Drug Discov       Date:  2009-01       Impact factor: 84.694

10.  Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation.

Authors:  Frank Niessen; Florence Schaffner; Christian Furlan-Freguia; Rafal Pawlinski; Gourab Bhattacharjee; Jerold Chun; Claudia K Derian; Patricia Andrade-Gordon; Hugh Rosen; Wolfram Ruf
Journal:  Nature       Date:  2008-02-27       Impact factor: 49.962

View more
  19 in total

1.  Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.

Authors:  J Robert Lane; Pavel Chubukov; Wei Liu; Meritxell Canals; Vadim Cherezov; Ruben Abagyan; Raymond C Stevens; Vsevolod Katritch
Journal:  Mol Pharmacol       Date:  2013-09-10       Impact factor: 4.436

Review 2.  Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes.

Authors:  Stuart L Schreiber; Joanne D Kotz; Min Li; Jeffrey Aubé; Christopher P Austin; John C Reed; Hugh Rosen; E Lucile White; Larry A Sklar; Craig W Lindsley; Benjamin R Alexander; Joshua A Bittker; Paul A Clemons; Andrea de Souza; Michael A Foley; Michelle Palmer; Alykhan F Shamji; Mathias J Wawer; Owen McManus; Meng Wu; Beiyan Zou; Haibo Yu; Jennifer E Golden; Frank J Schoenen; Anton Simeonov; Ajit Jadhav; Michael R Jackson; Anthony B Pinkerton; Thomas D Y Chung; Patrick R Griffin; Benjamin F Cravatt; Peter S Hodder; William R Roush; Edward Roberts; Dong-Hoon Chung; Colleen B Jonsson; James W Noah; William E Severson; Subramaniam Ananthan; Bruce Edwards; Tudor I Oprea; P Jeffrey Conn; Corey R Hopkins; Michael R Wood; Shaun R Stauffer; Kyle A Emmitte
Journal:  Cell       Date:  2015-06-04       Impact factor: 41.582

Review 3.  Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.

Authors:  Zhiwei Feng; Guanxing Hu; Shifan Ma; Xiang-Qun Xie
Journal:  AAPS J       Date:  2015-05-05       Impact factor: 4.009

4.  Selective coupling of the S1P3 receptor subtype to S1P-mediated RhoA activation and cardioprotection.

Authors:  Bryan S Yung; Cameron S Brand; Sunny Y Xiang; Charles B B Gray; Christopher K Means; Hugh Rosen; Jerold Chun; Nicole H Purcell; Joan Heller Brown; Shigeki Miyamoto
Journal:  J Mol Cell Cardiol       Date:  2016-12-23       Impact factor: 5.000

Review 5.  Sphingosine-1-phosphate metabolism: A structural perspective.

Authors:  Michael J Pulkoski-Gross; Jane C Donaldson; Lina M Obeid
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-04-29       Impact factor: 8.250

Review 6.  Sphingosine-1-phosphate receptors and innate immunity.

Authors:  Arielle M Bryan; Maurizio Del Poeta
Journal:  Cell Microbiol       Date:  2018-03-23       Impact factor: 3.715

7.  Bitopic Sphingosine 1-Phosphate Receptor 3 (S1P3) Antagonist Rescue from Complete Heart Block: Pharmacological and Genetic Evidence for Direct S1P3 Regulation of Mouse Cardiac Conduction.

Authors:  M Germana Sanna; Kevin P Vincent; Emanuela Repetto; Nhan Nguyen; Steven J Brown; Lusine Abgaryan; Sean W Riley; Nora B Leaf; Stuart M Cahalan; William B Kiosses; Yasushi Kohno; Joan Heller Brown; Andrew D McCulloch; Hugh Rosen; Pedro J Gonzalez-Cabrera
Journal:  Mol Pharmacol       Date:  2015-10-22       Impact factor: 4.436

Review 8.  Innovation in academic chemical screening: filling the gaps in chemical biology.

Authors:  Samuel A Hasson; James Inglese
Journal:  Curr Opin Chem Biol       Date:  2013-05-14       Impact factor: 8.822

9.  2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts.

Authors:  Amy Hauck Newman; Francisco O Battiti; Alessandro Bonifazi
Journal:  J Med Chem       Date:  2019-09-24       Impact factor: 7.446

Review 10.  New paradigms in GPCR drug discovery.

Authors:  Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2015-08-08       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.